Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem™) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate

This publication has 9 references indexed in Scilit:

• Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b‐CRM₁₉₇ conjugate vaccine
  Pediatrics International, 2003
• Immunogenicity and safety in infants of a DTwPHib full liquid vaccine
  Acta Paediatrica, 2003
• Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: a randomized trial
  The Pediatric Infectious Disease Journal, 2002
• Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine.
  The American Journal of Tropical Medicine and Hygiene, 2000
• Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of Conjugates
  Clinical Microbiology Reviews, 2000
• Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four ‘newly adopting’ countries
  Vaccine, 1999
• Haemophilus influenzae type b conjugate vaccines: a review of efficacy data
  The Pediatric Infectious Disease Journal, 1998
• Getting Hib vaccine to those who need it
  The Lancet, 1998
• Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens
  The Lancet, 1998